Literature DB >> 10456341

Oral and genital ulceration: a unique presentation of immunodeficiency in Athabascan-speaking American Indian children with severe combined immunodeficiency.

P C Kwong1, A S O'Marcaigh, R Howard, M J Cowan, I J Frieden.   

Abstract

BACKGROUND: Oral and genital ulcerations have been previously reported in 3 Navajo children diagnosed with severe combined immunodeficiency disease with T- and B-cell lymphopenia (T-B(-)-SCID).
OBJECTIVE: To evaluate the occurrence of oral and genital ulcerations in 12 Athabascan-speaking American Indians with a diagnosis of T-B(-)-SCID (SCIDA group) and to compare their occurrence in non-Athabascan-speaking children with SCID (control group). We also observed the course of these ulcerations in response to bone marrow transplantation (BMT).
DESIGN: Retrospective survey of the medical records of patients with SCID admitted from December 1, 1986, through July 31, 1995.
SETTING: Pediatric Bone Marrow Transplantation Division at a university hospital. PATIENTS: Twelve children in the SCIDA group and 21 in the control group. All patients had virtual absence of T- and B-cell numbers and function at time of diagnosis.
RESULTS: Oral and/or genital ulcers developed as a presenting feature of the SCIDA group. These ulcerations were not observed in the 21 controls. All patients underwent BMT. Of the 10 patients with oral and/or genital ulcerations, 3 had poor T-cell reconstitution after BMT, with recurrences of ulcers requiring additional BMTs.
CONCLUSIONS: Oral and/or genital ulcerations are common in Athabascan-speaking American Indian children with T-B(-)-SCID but are not seen in non-Athabascan-speaking children with SCID. Thus, oral and/or genital ulceration appears to be an important, distinctive finding, and often a presenting feature of immunodeficiency in Athabascan-speaking American Indian children with SCID. Bone marrow transplantation with successful T-cell engraftment appears to be curative in the resolution of the ulcers, with recurrences only in patients who had poor T-cell reconstitution.

Entities:  

Mesh:

Year:  1999        PMID: 10456341     DOI: 10.1001/archderm.135.8.927

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  A variant of SCID with specific immune responses and predominance of gamma delta T cells.

Authors:  Stephan Ehl; Klaus Schwarz; Anselm Enders; Ulrich Duffner; Ulrich Pannicke; Joachim Kühr; Françoise Mascart; Annette Schmitt-Graeff; Charlotte Niemeyer; Paul Fisch
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

2.  Radiosensitive severe combined immunodeficiency disease.

Authors:  Christopher C Dvorak; Morton J Cowan
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

Review 3.  Diversity upon diversity: linking DNA double-strand break repair to blood cancer health disparities.

Authors:  Jason N Sterrenberg; Melissa L Folkerts; Valeria Rangel; Sarah Eugenie Lee; Nicholas R Pannunzio
Journal:  Trends Cancer       Date:  2022-01-31

4.  Successful newborn screening for SCID in the Navajo Nation.

Authors:  Antonia Kwan; Diana Hu; Miran Song; Heidi Gomes; Denise R Brown; Trudy Bourque; Diana Gonzalez-Espinosa; Zhili Lin; Morton J Cowan; Jennifer M Puck
Journal:  Clin Immunol       Date:  2015-03-08       Impact factor: 3.969

5.  SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Authors:  Catharina Schuetz; Benedicte Neven; Christopher C Dvorak; Sandrine Leroy; Markus J Ege; Ulrich Pannicke; Klaus Schwarz; Ansgar S Schulz; Manfred Hoenig; Monika Sparber-Sauer; Susanne A Gatz; Christian Denzer; Stephane Blanche; Despina Moshous; Capucine Picard; Biljana N Horn; Jean-Pierre de Villartay; Marina Cavazzana; Klaus-Michael Debatin; Wilhelm Friedrich; Alain Fischer; Morton J Cowan
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

6.  Structure-Specific nuclease activities of Artemis and the Artemis: DNA-PKcs complex.

Authors:  Howard H Y Chang; Michael R Lieber
Journal:  Nucleic Acids Res       Date:  2016-05-19       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.